1997
DOI: 10.1007/s002770050271
|View full text |Cite
|
Sign up to set email alerts
|

Anti-HCV envelope prevalence in blood donors from Baden-Württemberg

Abstract: We assess the diagnostic value of the recombinant antigens E1/E2 (heterodimer) and E2 for the screening of blood donors. For this purpose an ELISA assay was developed which used these recombinant glycoproteins as solid antigens on the microtiter plates. The anti-E1/E2 assay was able to detect 80% of the positive samples by Matrix and 87% of the PCR-positive samples. Anti-E2 was less sensitive. Fifteen percent of the indeterminate samples were anti-E1/E2 and 8% anti-E2 positive. In the case of the indeterminate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…In several studies HCV core antigen based ELISA has been used as a screening method for the identification of HCV infection in human sera [29-31]. No screening method has been developed so far in Pakistan based on HCV types and isolates exist in this region and the sensitivity and specificity of the commercially available methods may be low for HCV strains common in Pakistan.…”
Section: Discussionmentioning
confidence: 99%
“…In several studies HCV core antigen based ELISA has been used as a screening method for the identification of HCV infection in human sera [29-31]. No screening method has been developed so far in Pakistan based on HCV types and isolates exist in this region and the sensitivity and specificity of the commercially available methods may be low for HCV strains common in Pakistan.…”
Section: Discussionmentioning
confidence: 99%